This article was about Gene Therapy for Metastatic Melanoma in Mice. The Indiana Unversity School of Medicine introduced melanoma T cell receptors to hematopoietic stem cells of mice. The T cells are deisnged to recongnize specific proteins of melanoma. After performing the transplantation assistant Professor Touloukian reported, "We found that the transplantation of gene-modified hematopoietic stem cells results in a new host immune system and the complete elimination of tumor." This research has helped for a new clinical trial for humans which will start by late 2011.
No comments:
Post a Comment